Profile
Nozait Chaudry-Rao joined OccuLogix, Inc. in February 2006 as Vice President of Clinical Research.
Previously, she worked at Boehringer Ingelheim, most recently as Director of the National Medicine Department.
From March 1993 to August 1996, Dr. Chaudry-Rao worked at Ciba-Geigy, where she held increasingly senior positons in drug development and clinical trial management.
She has served on several committees of the National Science and Engineering Research Committee of Canada and was a Lecturer at the University of Toronto.
Dr. Chaudry-Rao received a PhD in Clinical Pharmacology at the Royal Postgraduate Medical School in London, England.
Former positions of Nozait Chaudry-Rao
| Companies | Position | End |
|---|---|---|
| TEARLAB CORPORATION | Chief Tech/Sci/R&D Officer | 31/01/2008 |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
TearLab Corporation, Inc.
 TearLab Corporation, Inc. Medical SpecialtiesHealth Technology TearLab Corporation, Inc. engages in the development and marketing of a tear testing platform. Its primary product, the TearLab Osmolarity System, enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It measures tear film osmolarity for the diagnosis of dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Southlake, TX. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
- Stock Market
- Insiders
- Nozait Chaudry-Rao
